Pichl Daniel

Track

Insider profile

Pichl Daniel's trades of Springworks Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-02-12 2025-02-10
PlS Planned sale
5,023 -37.3%
117.71
US$1,279,504 		5,023 -37.3% 117.71 US$1,279,504
2025-02-12 2025-02-10
PlS Planned sale
99,210 +36.6%
195.07
US$396,633 		99,210 +36.6% 195.07 US$396,633
2025-02-12 2025-02-10
PlS Planned sale
12,293 +20.8%
263.81
US$1,005,383 		12,293 +20.8% 263.81 US$1,005,383
2025-02-10 2025-02-10
PrS Proposed sale
29,750
54.36
US$1,617,329 		29,750 54.36 US$1,617,329
2024-02-20 2024-02-16
PlS Planned sale
15,000 -24.9%
50.10
US$751,550 		15,000 -24.9% 50.10 US$751,550
2024-02-16 2024-02-16
PrS Proposed sale
15,000
50.00
US$750,000 		15,000 50.00 US$750,000
2024-02-05 2024-02-02
PlS Planned sale
743 -1.6%
46.44
US$34,507 		743 -1.6% 46.44 US$34,507
2024-02-05 2024-02-02
PlS Planned sale
1,997 -4.2%
45.95
US$91,756 		1,997 -4.2% 45.95 US$91,756
2024-02-05 2024-02-02
PlS Planned sale
14,175 -22.8%
44.31
US$628,157 		14,175 -22.8% 44.31 US$628,157
2024-02-05 2024-02-02
PlS Planned sale
9,266 -13.0%
43.81
US$405,942 		9,266 -13.0% 43.81 US$405,942
2024-02-02 2024-02-02
PrS Proposed sale
26,181
44.53
US$1,165,840 		26,181 44.53 US$1,165,840
2023-01-27 2023-01-26
PlS Planned sale
858 -2.4%
31.00
US$26,598 		858 -2.4% 31.00 US$26,598